期刊文献+

热疗联合放化疗治疗局部晚期直肠癌的疗效 被引量:1

The Curative Effect of Hyperthermia Combined Radiotherapy and Chemotherapy in Treatment of Locally Advanced Colorectal Cancer
在线阅读 下载PDF
导出
摘要 目的分析对局部晚期直肠癌患者实行放化疗联合热疗治疗的效果。方法选取60例在我院治疗的局部晚期直肠癌患者作为研究对象,分为A组与B组,各30例。A组患者实行放化疗联合热疗治疗,B组患者实行放化疗治疗,对比两组患者的疗效及疼痛缓解情况。结果治疗后,A组治疗总有效率90.00%,高于B组66.67%,疼痛缓解率93.33%,高于B组63.33%,差异具有统计学意义(P<0.05)。结论对局部晚期直肠癌患者实行放化疗联合热疗治疗,可提升患者治疗效果,减轻患者疼痛。 Objective Analysis of the effect of the implementation of chemotherapy combined with hyperthermia treatment of locally advancedcolorectal cancer patients.Methods Selected 60 patients with locally advanced colorectal cancer patients in our hospital as research subjects,which were divided into group A and group B,30 cases in each group.A group of patients with chemotherapy combined with hyperthermia therapy practice,the implementation of the B group of patients radiotherapy and chemotherapy,compared two groups of patients and the efficacy of pain relief.Results After treatment,A group the total effective rate was 90.00% higher than in group B 66.67%,pain relief was 93.33% higher than in group B 63.33%,the difference was significant(P0.05).Conclusion Implementation of chemotherapy combined with hyperthermia treatment of locally advanced colorectal cancer patients can improve patient outcomes,reduce patient pain.
作者 智会 李震
出处 《中国继续医学教育》 2016年第10期76-77,共2页 China Continuing Medical Education
关键词 放化疗 热疗 晚期直肠癌 疗效 Chemotherapy Hyperthermia Advanced colorectal cancer Efficacy
  • 相关文献

参考文献5

二级参考文献49

  • 1Holowaty P,Miller AB,Rohan T,et al.Natural history of dysplasia of the uterine cerix[J].J Nat Can Inst,1999,91:252.
  • 2殷蔚伯;余子豪;徐国镇.肿瘤放射治疗学[M]北京:中国协和医科大学出版社,20081191-1197.
  • 3孙燕;石远凯.临床肿瘤内科手册[M]北京:人民卫生出版社,2007258-260.
  • 4Natsugoe S, Matsumoto M, Okumura H, et al. Clinical course and outcome after esophagectomy with three - field lymphadenectomy in esophageal cancer[ J ]. Langenbeck Arch Surg, 2010,395 (4) : 341 - 346.
  • 5何平,杨国林,深部热疗加同步放化疗方案在局部晚期宫颈癌中的临床应用[J].四川医学,2014,35(1):102-103.
  • 6Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia[ J]. Crit Rev Oncol Hemato1,2012,43 ( 1 ) : 33 -56.
  • 7Vaughan S, Coward JI, Bast RC Jr, et al. Rethinking ovarian cancer: recommendations for improving outcomes[J]. Nat Rev Cancer, 2011, 11(10):719-725.
  • 8Cubillos-Ruiz JR, Baird JR, Tesone AJ, et al. Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer[J]. Cancer Res, 2012, 72(7):1683-1693.
  • 9Labidi-Galy SI, Sisirak V, Meeus P, et al. Quantitative and fun- ctional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer[J]. Cancer Res, 2011, 71(16):5423-5434.
  • 10Krempski J, Karyampudi L, Behrens MD, et al. Tumor-infil- trating programmed death receptor-1 + dendritic cells mediate immune suppression in ovarian cancer[J]. J Immunol, 2011, 186(12):6905-6913.

共引文献34

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部